Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.35 | -$0.35 | -$0.35 |
Q2 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
Q3 2024 | 2 | -$0.37 | -$0.20 | -$0.29 |
Q4 2024 | 1 | -$0.13 | -$0.13 | -$0.13 |
Q1 2025 | 1 | -$0.37 | -$0.37 | -$0.37 |
Q2 2025 | 1 | $0.29 | $0.29 | $0.29 |
Q3 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
Q4 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q1 2028 | 0 | $0.00 | $0.00 | $0.00 |
Q2 2028 | 0 | $0.00 | $0.00 | $0.00 |
Q3 2028 | 0 | $0.00 | $0.00 | $0.00 |
Q4 2028 | 0 | $0.00 | $0.00 | $0.00 |
CollPlant Biotechnologies Ltd. last posted its earnings results on Tuesday, August 20th, 2024. The company reported $-0.37 earnings per share for the quarter, missing analysts' consensus estimates of $-0.35 by $0.02. The company had revenue of 4,000 for the quarter and had revenue of 10.96 M for the year. CollPlant Biotechnologies Ltd. has generated $-1 earnings per share over the last year ($-0.62 diluted earnings per share) and currently has a price-to-earnings ratio of -2.34. CollPlant Biotechnologies Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 2nd, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/27/2024 | Q3 2024 | -$0.38 | $416,000 | $4,000 | ||
08/20/2024 | Q2 2024 | -$0.35 | -$0.37 | -0.02 | $395,500 | $249,000 |
04/04/2024 | Q1 2024 | -$0.37 | $98,000 | |||
04/04/2024 | Q4 2023 | -$0.41 | $299,000 | |||
11/29/2023 | Q3 2023 | -$0.13 | -$0.38 | -0.25 | $3.50 M | $43,000 |
05/24/2023 | Q2 2023 | -$0.29 | $0.51 | 0.8 | $3.59 M | $10.18 M |
03/29/2023 | Q1 2023 | -$0.21 | -$0.35 | -0.14 | $433,000 | |
03/29/2023 | Q4 2022 | -$0.21 | -$0.37 | -0.16 | $58,000 | |
12/01/2022 | Q3 2022 | -$0.31 | -$0.39 | -0.08 | $3.10 M | $109,000 |
05/26/2022 | Q2 2022 | -$0.14 | -$0.40 | -0.26 | $2.86 M | $66,000 |
03/24/2022 | Q1 2022 | -$0.26 | -$0.37 | -0.11 | $66,000 | |
11/18/2021 | Q4 2021 | -$0.28 | -$0.35 | -0.07 | $310,000 | |
11/18/2021 | Q3 2021 | -$0.28 | -$0.29 | -0.01 | $246,000 | $140,000 |
05/27/2021 | Q2 2021 | $0.51 | -$0.30 | -0.81 | $3.10 M | $691,000 |
03/26/2021 | Q1 2021 | -$0.30 | $1.20 | 1.5 | $14.50 M | |
12/01/2020 | Q4 2020 | $0.92 | -$0.42 | -1.34 | $557,000 | |
12/01/2020 | Q3 2020 | $0.92 | $0.10 | -0.82 | $4.15 M | |
04/01/2020 | Q2 2020 | -$0.13 | -$0.28 | -0.15 | $1.54 M | $823,000 |
04/01/2020 | Q1 2020 | -$0.13 | -$0.24 | -0.11 | $609,000 | |
04/01/2020 | Q4 2019 | -$0.13 | -$0.74 | -0.61 | $439,000 |
CollPlant Biotechnologies Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 2nd, 2025 based off last year's report dates.
The conference call for CollPlant Biotechnologies Ltd.'s latest earnings report can be listened to online.
The conference call transcript for CollPlant Biotechnologies Ltd.'s latest earnings report can be read online.
CollPlant Biotechnologies Ltd. (:CLGN) has a recorded annual revenue of $10.96 M.
CollPlant Biotechnologies Ltd. (:CLGN) has a recorded net income of $10.96 M. CollPlant Biotechnologies Ltd. has generated $-0.62 earnings per share over the last four quarters.
CollPlant Biotechnologies Ltd. (:CLGN) has a price-to-earnings ratio of -2.34 and price/earnings-to-growth ratio is -0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED